NCT04019314View on ClinicalTrials.gov

Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

October 6, 2021

Study Completion Date

October 6, 2021

Conditions
Heart FailureVolume OverloadDecompensated Heart FailureSystolic Heart Failure
Interventions
PROCEDURE

Blood Collection

Samples for proEnkephalin PENK will be obtained daily and aliquots of these samples will be stored for later batch assays.

PROCEDURE

Blood Volume Analysis

A small amount of a radioactive isotope or tracer is injected and blood samples are taken at 6 time points during the test and analyzed.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Sphingotec GmbH

INDUSTRY

lead

Mayo Clinic

OTHER

NCT04019314 - Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI) | Biotech Hunter | Biotech Hunter